p53 and MDM2 expression in odontogenic cysts and tumours

被引：0
|
作者：
Carvalhais, JN
de Aguiar, MCF
de Araújo, VC
de Araújo, NS
Gomez, RS
机构：
[1] Univ Fed Minas Gerais, Sch Dent, Dept Oral Surg & Pathol, BR-30380030 Belo Horizonte, MG, Brazil
[2] Univ Sao Paulo, Sch Dent, Dept Oral Pathol, Sao Paulo, Brazil
来源：
ORAL DISEASES | 1999年 / 5卷 / 03期
关键词：
p53; MDM2; odontogenic cysts; odontogenic tumours; immunohistochemistry;
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
OBJECTIVE: The aim of this report was to assess p53 and MDM2 expression in odontogenic cysts and tumours, as they are known to play important roles in cell proliferation and tumorigenesis. MATERIALS AND METHODS: The expression of p53 and MDM2 proteins was determined immunohistochemically in 51 formalin-fixed, paraffin embedded specimens of odontogenic cysts and tumours. RESULTS: No positivity to p53 was found in the cases studied. MDM2 expression in ameloblastoma was higher than in radicular cysts, but lower than that observed in odontogenic keratocysts. No difference was observed between MDM2 expression in radicular cyst and adenomatoid odontogenic tumour. The clear-cell odontogenic ametoblastoma presented strong immunoreaction to this antigen. CONCLUSIONS: The results suggest that MDM2 overexpression may be involved in the pathogenesis of some odontogenic lesions.
引用
收藏
页码：218 / 222
页数：5
相关论文
共 50 条
  • [41] Immunohistochemical analysis of P53 protein in odontogenic cysts
    Gaballah, Essam Taher M. A.
    Tawfik, Mohamed A.
    SAUDI DENTAL JOURNAL, 2010, 22 (04) : 167 - 170
  • [42] Mdm2 and MdmX partner to regulate p53
    Wang, Xinjiang
    Jiang, Xuejun
    FEBS LETTERS, 2012, 586 (10) : 1390 - 1396
  • [43] DETECTION OF P53 AND MDM2 PROTEIN EXPRESSION IN HEAD AND NECK CARCINOGENESIS
    GIROD, SC
    CESARZ, D
    FISCHER, U
    KRUEGER, GRF
    ANTICANCER RESEARCH, 1995, 15 (04) : 1453 - 1457
  • [44] Mdm2: keeping p53 under control
    Jacques Piette
    Henry Neel
    Vincent Maréchal
    Oncogene, 1997, 15 : 1001 - 1010
  • [45] The p53 isoforms are differentially modified by Mdm2
    Camus, Suzanne
    Menendez, Sergio
    Fernandes, Kenneth
    Kua, Nelly
    Liu, Geng
    Xirodimas, Dimitris P.
    Lane, David P.
    Bourdon, Jean-Christophe
    CELL CYCLE, 2012, 11 (08) : 1646 - 1655
  • [46] Expression of p53, MDM2 protein and Ki-67 antigen in recurrent meningiomas
    Mitsuaki Ohkoudo
    Hiroki Sawa
    Mitsuhiro Hara
    Kazuhiko Saruta
    Toshiko Aiso
    Reiko Ohki
    Hiroshi Yamamoto
    Eiji Maemura
    Yoshio Shiina
    Masahiko Fujii
    Isamu Saito
    Journal of Neuro-Oncology, 1998, 38 : 41 - 49
  • [47] p53 and MDM2 immunostaining in pulmonary blastomas and bronchogenic carcinomas
    Pacinda, SJ
    Ledet, SC
    Gondo, MM
    Langston, C
    Brown, RW
    Carmona, PA
    Franklin, RB
    Roggli, VL
    Cagle, PT
    HUMAN PATHOLOGY, 1996, 27 (06) : 542 - 546
  • [48] Activation of p53 by roscovitine-mediated suppression of MDM2 expression
    Wenge Lu
    Lihong Chen
    Yanhua Peng
    Jiandong Chen
    Oncogene, 2001, 20 : 3206 - 3216
  • [49] The p53–Mdm2–HAUSP complex is involved in p53 stabilization by HAUSP
    C L Brooks
    M Li
    M Hu
    Y Shi
    W Gu
    Oncogene, 2007, 26 : 7262 - 7266
  • [50] The expression of MDM2, MDM4, p53 and p21 in myeloid neoplasms and the effect of MDM2/MDM4 dual inhibitor
    Eskandari, Mohammad
    Shi, Yang
    Liu, John
    Albanese, Joseph
    Goel, Swati
    Verma, Amit
    Wang, Yanhua
    LEUKEMIA & LYMPHOMA, 2021, 62 (01) : 167 - 175
12345